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Modulation of Cardiac Growth and Development
by HOP, an Unusual Homeodomain Protein
embryo and linking extracellular signals to tissue-spe-
cific gene regulatory programs (reviewed in Gehring et
al., 1994). The homeodomain is encoded by a DNA se-
Chong Hyun Shin,1,6 Zhi-Ping Liu,1,6
Robert Passier,1,4,6 Chun-Li Zhang,1 Da-Zhi Wang,1
Thomas M. Harris,3 Hiroyuki Yamagishi,1
quence referred to as the homeobox. Homeobox genesJames A. Richardson,2 Geoffrey Childs,3
are found in all eukaryotic organisms, and over 160 haveand Eric N. Olson1,5
potentially been identified in the human genome. Ho-1Department of Molecular Biology
meodomain proteins can be categorized into different2 Department of Pathology
classes based on amino acid sequence homologiesUniversity of Texas Southwestern Medical Center
within the homeodomain and their expression patterns.at Dallas
A subset of homeobox genes located in clusters confers6000 Harry Hines Boulevard
positional information along the antero-posterior axisDallas, Texas 75390
of the embryo. Numerous other homeobox genes are3 Department of Molecular Genetics
distributed throughout the genome and show uniqueAlbert Einstein College of Medicine
expression patterns.1300 Morris Park Avenue
The homeodomain is comprised of 60 amino acidsBronx, New York 10461
that adopt three  helices, with a characteristic helix-4 Hubrecht Laboratory
turn-helix motif (reviewed in Kornberg, 1993). Helix-3,Uppsalalaan 8
referred to as the recognition helix, lies in the major3584CT Utrecht
groove of the DNA binding site and makes direct contactThe Netherlands
with the DNA. Amino acid variations within the recogni-
tion helix dictate DNA binding site specificity of different
homeodomain proteins. Additional specificity of DNASummary
binding is contributed by a flexible region, called the
N-terminal arm, that extends from the first helix andWe have discovered an unusual homeodomain pro-
wraps around the DNA to make contacts with the minortein, called HOP, which is comprised simply of a ho-
groove.meodomain. HOP is highly expressed in the develop-
Target gene specificity of different homeodomain pro-ing heart where its expression is dependent on the
teins that bind the same DNA sequence is achievedcardiac-restricted homeodomain protein Nkx2.5. HOP
through differential association with positive and nega-does not bind DNA and acts as an antagonist of serum
tive cofactors. Such interactions can occur between ho-response factor (SRF), which regulates the opposing
meodomain proteins and other transcriptional regula-processes of proliferation and myogenesis. Mice ho-
tors that bind adjacent sequences in regulatory DNA ormozygous for a HOP null allele segregate into two
by direct protein-protein interactions in the absence ofphenotypic classes characterized by an excess or defi-
DNA binding. A classic example of such combinatorialciency of cardiac myocytes. We propose that HOP
interactions is illustrated by the yeast homeodomainmodulates SRF activity during heart development; its
protein MAT2, which interacts with the MADS (MCM1,absence results in an imbalance between cardiomyo-
Agamous, Deficiens, and serum response factor) boxcyte proliferation and differentiation with consequent
transcription factor MCM1, resulting in repression ofabnormalities in cardiac morphogenesis.
a-specific genes (Smith and Johnson, 1992). Similarly,
homeodomains of the Paired-type associate with serumIntroduction
response factor (SRF), a MADS box factor that controls
the expression of genes involved in cell proliferation and
Organ formation during embryogenesis requires the myogenesis (Norman et al., 1988; Reecy et al., 1998).
commitment of multipotent progenitor cells to specific Association of SRF with the phox/prx1 homeodomain
lineages, the activation of tissue-specific genes, and the protein enhances the binding of SRF to DNA (Gruene-
precise spatial organization of specialized cell types. A berg et al., 1992). The association of MADS box proteins
tightly regulated balance between cell proliferation and like MCM1 and SRF with homeodomain proteins cou-
differentiation is also required to generate and maintain ples cell identity with signal responsiveness, thereby
the size and shape of the mature organ. These pro- providing a mechanism for cell type-specific responses
cesses are controlled by combinatorial interactions be- to “generic” signals.
tween cell-specific and broadly expressed transcription The cardiac-restricted homeodomain protein, Nkx2.5,
factors that act through positive and negative mecha- also associates with SRF, resulting in cooperative acti-
nisms to govern arrays of target genes in distinct tempo- vation of cardiac genes (Chen and Schwartz, 1996; Sep-
rospatial patterns. ulveda et al., 2002). Nkx2.5, which is among the earliest
Members of the homeodomain family of transcription markers of heart formation in vertebrate embryos (Lints
factors play key roles in organogenesis and embryonic et al., 1993), is an ortholog of tinman, a homeobox gene
patterning by interpreting positional information in the required for heart formation in Drosophila (reviewed in
Harvey, 1996). Nkx2.5 is expressed throughout the de-
veloping and adult heart (Lints et al., 1993). Mice homozy-5 Correspondence: eolson@hamon.swmed.edu
6 These authors contributed equally to this work. gous for an Nkx2.5 null allele die during embryogenesis
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Figure 1. Sequence Comparison of HOP and Other Homeodomain Proteins
(A) Alignment of the deduced amino acid sequences of mouse and human HOP proteins.
(B) Sequence comparison of the homeodomain of mouse HOP with other homeodomains. Amino acid positions within the 60 amino acid
homeodomain are shown.
(C) Localization of HOP protein to the nucleus in primary rat cardiomyocytes. Myocytes were stained with anti-HOP antibody.
from myogenic and morphologic cardiac abnormalities of DNA binding by determining base preferences and is
a signature residue for different types of homeodomains.(Lyons et al., 1995; Tanaka et al., 1999).
Here we describe an unusual homeodomain protein, The lysine at this position in HOP is characteristic of
the paired-type homeodomain subclass, which includescalled Homeodomain-Only Protein (HOP), which is ex-
pressed in the developing heart where it is regulated by Pax-6 and goosecoid. Glutamine-11, leucine-15, phe-
nylalanine-19, alanine-35, leucine-40, and arginines-52Nkx2.5. We originally named this protein Cameo (cardiac
homeodomain) and Epstein and coworkers, who discov- and -57 are also highly conserved in other homeodo-
mains and are present in HOP.ered it independently, named it Toto (Chen et al., 2002
[this issue of Cell]). Through the generation of mice lack- There are also several divergent amino acids within
the HOP homeodomain, some of which would be pre-ing HOP, we show that HOP acts at multiple steps in
the pathway for heart development. dicted to be incompatible with efficient DNA binding. For
example, the nine amino acids immediately preceding
helix-1 of other homeodomains contain highly con-Results
served basic residues that extend across the DNA bind-
ing site and make contact with the DNA minor groove.Structure of the HOP Homeodomain
There are no basic residues in this region of HOP andWe performed a bioinformatics screen of expressed se-
there is a Gly-Pro sequence that would alter the struc-quence tag (EST) databases using a homeodomain con-
ture of this amino-terminal arm. HOP contains a gluta-sensus sequence to identify unknown homeobox genes
mine at position 51, whereas every other metazoan ho-expressed in the developing heart. One potential homeo-
meodomain contains an asparagine at this position,box sequence we identified and subsequently cloned from
which makes identical base-specific contacts with aa mouse heart cDNA library appeared to encode an un-
conserved adenine in the binding sites of all homeodo-usually small 73 amino acid homeodomain protein,
main structures that have been determined (Kornberg,which we named Homeodomain-Only Protein (HOP; Fig-
1993). Residues 53 and 55 are also almost always argi-ure 1A). There were multiple in-frame termination co-
nine and lysine, respectively, in other homeodomains,dons upstream of the initiating methionine in the HOP
whereas in HOP these residues are leucine and glutamiccDNA sequences, indicating that this is the complete
acid. Since these residues of other homeodomains makeopen reading frame. The predicted mouse HOP protein
direct contact with the DNA through electrostatic inter-has a Mr  8.3 kDa and a pI of 4.64. Mouse and rat
action, the presence of hydrophobic and negativelycDNA sequences encoding identical HOP proteins and
charged residues at these positions is unfavorable fora human sequence with six amino acid differences were
DNA binding.identified (Figure 1A). We did not identify a HOP-like
We tested whether a bacterial GST-HOP fusion pro-sequence in Drosophila or Caenorhabditis elegans ge-
tein was able to bind DNA by performing gel mobilitynome sequences, suggesting that this gene may be spe-
shift assays with binding sites for other homeodomaincific to vertebrates.
proteins and by PCR-mediated binding site selectionHOP is an unusually small homeodomain protein. Sec-
assays with random oligonucleotide probes. No DNAondary structural predictions indicate that HOP forms
binding of HOP was observed. Nevertheless, immuno-threehelices with a helix-turn-helix motif characteristic
staining of isolated rat cardiomyocytes with an anti-of the homeodomain. The HOP homeodomain contains
HOP antibody showed that HOP protein was localizednumerous residues that are highly conserved through-
predominantly to the nucleus (Figure 1C).out the homeodomain superfamily (Figure 1B). The WF
motif at residues 48 and 49 of the homeodomain is
conserved in almost all homeodomain proteins and par- Expression of HOP
During mouse embryogenesis, HOP transcripts weretially defines this class of transcription factors. Residue
50 within the recognition helix controls the specificity first detected at E7.75 in trophoblasts within extraem-
Roles of HOP in Heart Development
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Figure 2. Expression Pattern of HOP during
Mouse Embryogenesis and in Adult Mouse
Tissues
(A) In (a–e), HOP transcripts were detected by
whole-mount in situ hybridization to mouse
embryos at (a) E7.75, (b) E8.0, (c) E8.5, (d)
E9.5, and (e) E11.5. In (f–j), HOP transcripts
were detected by in situ hybridization to
transverse sections as follows: (f) staining in
lateral mesoderm and heart tube at E8.5, (g)
staining throughout the atrial and ventricular
chambers at E12.5, (h) staining in heart and
neural tube at E14.5, (i) high magnification of
neural tube at E12.5, and (j) staining in heart
and lungs at E16.5. a, atrium; ba, branchial
arch; cc, cardiac crescent; h, heart; hf, head
fold; ht, heart tube; l, lung; v, ventricle.
(B) Detection of HOP mRNA by Northern blot
of adult mouse tissues. Equal amounts of
RNA were loaded in each lane.
(C) In situ hybridization of sagittal sections of
wild-type and Nkx2.5/ embryos, as indi-
cated. HOP transcripts are not detected in
the heart of the Nkx2.5/ mutant. MLC2A
transcripts are detected in embryos of both
genotypes, confirming integrity of mRNA in
the mutant.
bryonic membranes (data not shown). At E7.75, HOP a left ventricular chamber (Lyons et al., 1995). HOP was
expressed at normal levels in mice lacking the bHLHtranscripts were detected in the lateral wings of the
cardiac crescent and in the anterior head folds (Figure transcription dHAND, which fail to form a right ventricle
(Srivastava et al., 1997), or MEF2C, which show abnor-2A, a). Expression of HOP in the cardiac crescent lags
behind that of Nkx2.5 by about 8 hr and is less extensive; mal atrial and ventricular development (Lin et al., 1997;
data not shown). We conclude that HOP expression iswhereas Nkx2.5 is expressed throughout the cardiac
crescent (Lints et al., 1993), HOP expression is restricted dependent on Nkx2.5 during the early stages of heart
development.to the lateral domains. At E8.0, HOP expression was
detected along the length of the linear heart tube and
in the head folds (Figure 2A, b). At E8.5 to 9.5, expression Generation of HOP Mutant Mice
To investigate the function of HOP in vivo, we generatedwas also observed in the branchial arches and lateral
mesoderm dorsal to the heart (Figure 2A, c, d, and f). HOP null mice by gene targeting (Figures 3A and 3B).
Our targeting vector deleted the entire coding regionExpression was maintained throughout the ventricular
and atrial chambers of the heart through E14.5 (Figure and introduced a nuclear-localized lacZ protein-coding
region in-frame with the initiation codon of HOP.2A, e, g, and h). Beginning at about E12.5, we also
observed HOP expression within the periventricular Mice heterozygous for the HOP null mutation were
intercrossed to obtain HOP null offspring in the isogeniczone of the neural tube, and by E16.5, expression of
HOP was observed in the epithelium of the developing 129Sv background, as well as in the 129Sv/C57BL6
mixed background. In the mixed genetic background,airways of the lungs (Figure 2A, i and j). A single HOP
transcript of 1.3 kb was detected in adult mouse heart, viable homozygous mutants were obtained at postnatal
day 10 (P10) at a frequency that approximated Mende-lung, brain, and liver (Figure 2B).
lian ratios (Table 1). However, in the isogenic 129Sv
background, viable homozygous mutants were under-Dependence of HOP Expression on Nkx2.5
To begin to determine whether HOP might act within represented at a frequency of 17% compared to the
predicted 25% (Table 1). These findings suggested thatthe network of genes that controls heart formation, we
examined its expression in a series of mouse mutants the HOP mutant phenotype resulted in embryonic lethal-
ity with variable penetrance.with abnormalities in specific steps of cardiac develop-
ment. Cardiac expression of HOP was downregulated Northern blot and RT-PCR analysis of RNA from heart
and liver of HOP null mice confirmed that the targetedin Nkx2.5 mutant embryos (Figure 2C), which fail to form
Cell
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Table 1. Genotypes of Offspring from HOP/ Intercrosses
Offspring of Each Genotype
Genetic
Background / / /
129 32 (25%) 74 (58%) 22 (17%)
129/BL6 30 (21%) 83 (56%) 34 (23%)
Genotypes of mice from HOP/ intercrosses were determined at
P10. Absolute numbers of mice of each genotype are shown and the
percent of total is in parentheses. In the isogenic 129Sv background,
homozygous HOP mutants represented 17% of offspring at P10,
which is lower than expected from Mendelian ratios (p  0.05). In
the mixed 129Sv/BL6 background, the frequency of homozygous
HOP mutants was not statistically different from Mendelian ratios.
to the adjacent compact zone in the ventricular wall
(Figure 3F, d and e). LacZ staining was also observed
within the neural tube (Figure 3F, b).
Embryonic Cardiac Defects in HOP Mutant Mice
In light of the lower than predicted number of viable
HOP mutant mice in the isogenic 129Sv background, we
examined embryos from timed pregnancies of HOP/
intercrosses for possible lethal defects. We did not de-
tect abnormal embryos prior to E9.5. However, at E11.5,
approximately 10% of embryos showed arrested devel-
opment (Figure 4, compare A and B). Genotyping con-
firmed that these were homozygous mutants. The hearts
from these embryos did not show gross morphologic
abnormalities, but the ventricular myocardium was ex-
tremely thin and hypocellular (Figure 4, compare C and
E with D and F). There were also numerous ruptures
throughout the ventricular walls, and there was a bloody
pericardium. These findings suggest that HOP is re-
quired in a relatively small subset of isogenic embryos
Figure 3. Generation of HOP Mutant Mice to establish the appropriate number of cardiac myocytes
(A) Strategy for targeting the mouse HOP gene by homologous needed for the heart to sustain hemodynamic load be-
recombination. yond E11.5.
(B) Southern blot analysis of genomic DNA from a wild-type and
HOP/ mouse.
Cardiomyocyte Hyperplasia in HOP Mutant Mice(C) Detection of HOP transcripts by Northern blot analysis.
Since the majority of HOP mutants were viable, we ana-(D) Detection of HOP transcripts by RT-PCR.
(E) Detection of HOP protein by Western blot analysis. The HOP lyzed them for possible cardiac abnormalities after birth.
protein of 9 kDa was detected in heart from wild-type but not from Viable HOP mutant mice in the isogenic 129Sv and mixed
homozygous mutant mice. genetic backgrounds had hearts with increased ventric-
(F) Expression of lacZ from the targeted HOP allele. (a) E11.5, (b
ular wall thickness compared to control littermates (Fig-and c) E12.5, (d and e) H and E sections of the heart of an E11.5
ure 5A). At P1, the heart weight/body weight ratio inembryo at low (d) and high (e) magnification. Nuclear lacZ staining
mutant mice was approximately 20% higher than in wild-is largely confined to the trabecular region.
type littermates. This increase in relative cardiac size
was maintained until adulthood (Figure 5B).
Histologic examination and DAPI staining of mutantmutation eliminated expression of HOP mRNA (Figures
3C and 3D). Western blot analysis from brain and heart hearts suggested that the increase in size at early ages
was largely due to an increase in cardiomyocyte cellof HOP null mice also showed that the HOP protein of
9 kDa was absent in homozygous mutants (Figure 3E number rather than hypertrophy (Figure 5A). This was
confirmed by dissociating hearts from wild-type andand data not shown).
mutant littermates and performing cell counts that dis-
tinguished cardiac myocytes from fibroblasts. As shownLacZ Expression from the Targeted HOP Allele
Embryos harboring the HOP mutation expressed lacZ in Figure 5C, there was approximately a 30% increase
in the number of cardiac myocytes in mutant hearts atin a pattern corresponding to that of the endogenous
HOP gene (Figure 3F). Cardiac expression of lacZ was P1 and P28. The size of cardiomyocytes was similar in
mutant and wild-type mice up to 4 weeks of age.especially prominent after E10.5 (Figure 3F, a–c). Serial
sections of the heart at E11.5 revealed the highest levels At six months of age, a subset of mutant mice devel-
oped severely enlarged and dilated hearts with fibrosisof lacZ staining within cardiomyocyte nuclei in the tra-
becular zone, where proliferation is diminished relative (Figure 5D). Histological analysis revealed that myocytes
Roles of HOP in Heart Development
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bers were observed in at least two-thirds of mutant mice,
but there was variability in cell number.
Altered Gene Expression in Hearts from HOP
Mutant Mice
In an effort to identify possible molecular defects in
HOP mutant cardiomyocytes, we compared the gene
expression profiles of wild-type and mutant hearts at
P1 by microarray analysis (Table 2). According to our
selection criteria for signal strength, background, ex-
pression ratio, and reproducibility, a total of 179 genes
showed elevated expression and 90 showed reduced
expression in mutants compared to controls. Numerous
genes involved in cell proliferation were upregulated in
mutant hearts. These included genes encoding cyclin
D3 and basic transcription element binding protein
1(BTEB1) (Zhang et al., 2001a). HOP mutants also
showed elevated expression of fetal genes that are typi-
cally associated with a cardiac stress response, includ-
ing those encoding -MHC, atrial natriuretic factor
(ANF), b-type natriuretic factor (BNP), and skeletal
-actin. Interestingly, several smooth muscle-restricted
genes, including those encoding SM22, calponin,
smooth muscle -actin, -actinin-2, and cysteine-rich
protein-2 (CRP2) were upregulated in mutant hearts. The
changes in expression of several of the above genes
were confirmed by RT-PCR analysis (Figure 6A).
Interference with SRF Activity by HOP
A striking number of the genes that were upregulated
in the HOP mutant hearts were known targets for SRF
Figure 4. Abnormalities in Cardiac Development in HOP Mutant Mice (Table 2). We therefore tested whether HOP affected the
(A and B) Wild-type and HOP mutant embryos at E11.5. The HOP activity of the ANF, -cardiac actin, and SM22 promot-
mutant shows abnormal cardiac morphology and pericardial hemor- ers, which contain essential SRF binding sites. HOP
rhaging. alone had no effect on these promoters, but it reduced
(C and D) H and E sections of wild-type and HOP mutant embryos
the level of promoter activity in the presence of SRFat E11.5.
(Figure 6B). SRF has been shown to interact with Nkx2.5(E and F) The boxed regions in (C) and (D). Note the thin-walled
and GATA4, resulting in synergistic activation of themyocardium in the mutant.
ANF and cardiac-actin promoters (Chen and Schwartz,
1996). This synergy was suppressed by HOP in a dose-
dependent manner (Figure 6B).in these hearts were hypertrophic. Echocardiography of
SRF also synergizes with the cardiac transcriptionalHOP mutant mice did not detect abnormalities in cardiac
cofactor, myocardin, which interacts with the MADS boxcontractility or function, except in the subset of mutants
of SRF (Wang et al., 2001). HOP diminished the respon-that developed late-onset hypertrophy (data not shown).
siveness of the SM22 and ANF promoters to myocardin
(Figure 6B). The inhibitory effects of HOP on SRF activity
were dose-dependent, but incomplete. Typically, we ob-Delayed Withdrawal of HOP Mutant Cells
from the Cell Cycle served up to 50% inhibition of SRF activity in the pres-
ence of HOP. Higher amounts of HOP expression plas-Cardiac muscle cells normally begin to withdraw from
the cell cycle at birth. To determine whether the increase mid did not result in greater inhibition.
To begin to determine the mechanism whereby HOPin cardiomyocyte cell number in HOP mutants was asso-
ciated with prolonged proliferation, we stained histo- repressed SRF-dependent gene transcription, we per-
formed gel mobility shift assays with SRF and HOP pro-logical sections of P1 hearts with antibody against
phospho-histone H3, a marker of mitosis. Whereas teins translated in vitro and a radiolabeled SRF binding
site as a probe. HOP alone showed no detectable DNAphospho-H3-positive cells were observed only occa-
sionally in wild-type hearts, they were widespread in binding and it diminished the binding of SRF in a dose-
dependent manner (Figure 6C).the mutant hearts (Figure 5E). There were 19-fold more
phospho-H3-positive cells in mutant than wild-type We tested whether 35S-methionine-labeled HOP pro-
tein translated in vitro could associate with a GST-SRFhearts. No phospho-H3-positive cardiomyocytes were
detected in mutant or wild-type littermates at 4 weeks fusion protein. Association of 35S-methionine-labeled
HOP with GST-SRF was readily detected in this assay,of age (data not shown), suggesting that cardiomyocyte
proliferation was prolonged only during the neonatal whereas no interaction of labeled HOP with GST alone
was observed (Figure 6D). Immunoprecipitation assaysperiod in the mutant. Increased cardiomyocyte cell num-
Cell
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Figure 5. Cardiomyocyte Hyperplasia in HOP Mutant Mice
(A) Hearts from wild-type and HOP mutant mice at P1 were sectioned and analyzed by H and E staining (top). The lower images show DAPI
staining of sections from the interventricular septum of wild-type and HOP mutant hearts.
(B) Heart weight/body weight ratios of wild-type and HOP mutant mice were determined at the indicated postnatal days. The bars indicate
the average ratios for each group. Statistical significance of differences between wild-type and HOP/ at each day were as follows: P1, p 
0.02; P4, p  0.005; P28, p  0.05.
(C) Hearts from wild-type and HOP mutant mice were dissociated and cardiomyocyte numbers were determined. Values represent the number
of cells in a 1 mm2 chamber. Cardiomyocytes were distinguished from fibroblasts by size and the presence of sarcomeres. P  0.01 versus
wild-type.
(D) Histological sections of hearts from wild-type and HOP mutants at six months of age. The mutant heart is hypertrophic.
(E) Representative histological sections from wild-type and HOP mutant hearts were stained with anti-phospho-histone H3 antibody. The
number of positive cells from five different hearts of each genotype was quantified and is shown beneath each image.
Table 2. Genes Upregulated in HOP Mutant Hearts
Genes Increase in Expression SRF Target
Growth-associated genes
Cyclin D3 3x ?
BTEB1/Kruppel-like factor 5x ?
Early growth factor response gene 3x yes
Homer immediate early gene 3x ?
Defender Against Death (DAD1) 3x ?
Smooth muscle genes
SM22 2x yes
Calponin 3x yes
Smooth muscle alpha-actin 2x yes
Alpha-actinin-2 3x ?
Cysteine-rich protein-2 3x yes
Cardiac muscle genes
ANF 5x yes
BNP 5x ?
SERCA 3x yes
Skeletal alpha-actin 2x yes
Beta-MHC 15x yes
Cardiac MLC 3x yes
Myosin binding protein-C 10x ?
Selected genes that were upregulated in HOP mutant hearts at P1 are shown. Relative increases in expression from microarray analysis are
shown. Most changes were confirmed by RT-PCR analysis. Genes that are known to regulated by SRF in previous studies are indicated
“yes” and genes not shown to be regulated by SRF are indicated “?”.
Roles of HOP in Heart Development
731
Figure 6. Changes in Gene Expression in Hearts from HOP Mutant Mice and Modulation of SRF Activity by HOP
(A) RT-PCR analysis of selected genes in P1 hearts of wild-type and HOP mutant mice.
(B) COS-1 cells (left three images) or cardiomyocytes (right image) were transiently transfected with the indicated luciferase reporters and
expression vectors encoding HOP, SRF, Nkx2.5, GATA4, and myocardin, as described in Experimental Procedures. Values are expressed as
relative luciferase activity compared to the maximum level. Representative experiments are shown. All assays were performed at least three
times with comparable results.
(C) SRF and increasing amounts of HOP were translated in vitro and used in gel shift assays with a radiolabeled probe corresponding to the
c-fos CArG box. Parallel translation reactions containing [35S]-methionine were used to quantify relative amounts of translated proteins (not
shown).
(D) GST-pull down assays. 35S-methionine-labeled HOP protein was incubated with GST or GST-SRF, followed by binding to glutathione-
agarose beads. Labeled proteins were resolved by SDS-PAGE. One-tenth of 35S-methionine-labeled HOP protein used in GST-SRF pull-down
assays was loaded in the input lane.
(E) Coimmunoprecipitation of Flag-tagged HOP and HA-tagged SRF from transiently transfected 293T cells. Immunoprecipitations were carried
out with agarose-conjugated anti-Flag antibody. Immunoprecipitates were separated by SDS-PAGE and subsequently immunoblotted with
anti-HA antibody (right image). One-tenth of the cell extract was immunoblotted with anti-HA antibody as input (left image).
from 293T cells cotransfected with expression plasmids (HLH) protein Id, which lacks a DNA binding domain and
forms inactive heterodimers with basic HLH proteinsencoding Flag-tagged HOP and HA-tagged SRF pro-
teins also revealed an interaction between HOP and (Benezra et al., 1990). In light of the ability of homeodo-
main proteins to associate with HLH and GATA tran-SRF. Using a series of SRF deletion mutants, we found
that the MADS box of SRF mediated interaction with scription factors (Lee et al., 1998; Sun et al., 2001), which
play key roles in cardiac development (Srivastava andHOP (Figure 6E). A weaker, but still significant, interac-
tion was also observed between HOP and the C-terminal Olson, 2000), it will be of interest to determine whether
HOP has additional positive or negative partners in theregion (residues 266–508) of SRF. An SRF mutant that
cannot bind DNA (mutant pm1, Chen and Schwartz, cardiac lineage.
A variety of homeodomain proteins have been shown1996) was also able to interact with HOP.
to associate with SRF, but HOP is unique in its antago-
Discussion
HOP is an unusual homeodomain protein that modulates
cardiac growth and development. The phenotypes of
HOP mutant mice suggest that HOP acts at two stages
of heart development; prior to E11.5, it is involved in
expansion of the ventricular myocardium, and later in
fetal development it restricts cardiomyocyte prolifera-
tion. The effects of HOP on the developing heart corre-
late with its action as an antagonist of SRF, which plays
a dual role in regulating gene expression during cell
growth and muscle cell differentiation (Figure 7).
Negative Regulation of SRF Activity by HOP
The properties of HOP are reminiscent of those of I-POU,
Figure 7. A Model for the Modulation of SRF Activity by HOP
a member of the POU-homeodomain family that cannot
SRF regulates the opposing processes of cell proliferation and dif-bind DNA and inhibits the activity of other POU-domain
ferentiation. HOP antagonizes the activity of SRF. In the absence
transcription factors by forming inactive heterodimeric of HOP, the balance between proliferation and differentiation is
complexes (Treacy et al., 1991). This type of inhibitory disrupted with resulting excess or deficiency of cardiomyocytes,
depending on other factors and signals.activity is also analogous to that of the helix-loop-helix
Cell
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nism of SRF DNA binding. The homeodomain protein pression becomes restricted to the trabecular region,
where the proliferative rate of cardiomyocytes is dimin-prx1 enhances SRF activity by increasing the on-rate
for DNA binding (Grueneberg et al., 1992). Nkx2.5 also ished relative to the adjacent compact zone (Pasumarthi
and Field, 2002). Embryonic day 11.5 appears to repre-binds DNA cooperatively with SRF, resulting in syner-
gistic activation of SRF-dependent cardiac target genes sent a critical stage in heart development with respect
to HOP activity, since a subset of HOP mutant embryos(Chen and Schwartz, 1996; Sepulveda et al., 2002). Like-
wise, the Barx2 homeodomain protein associates with dies at this stage from cardiac insufficiency. The abnor-
malities in these mutant embryos appear to be cellularSRF and stimulates DNA binding, although the physio-
logic significance of this interaction has not been deter- rather than morphologic, as looping morphogenesis and
atrioventricular chamber formation occurs normally, butmined (Herring et al., 2001). HOP could interfere with
SRF DNA binding by interference with critical contacts affected embryos have fewer cardiomyocytes and a
thin-walled myocardium.between residues that make essential base contacts or
by disrupting SRF dimerization. Mutant embryos that can survive past E11.5 progress
to birth and show an excess of cardiomyocytes. ThisPrevious studies of other homeodomains have dem-
onstrated that helices 1 and 2, which form a virtually phenotype seems to result from prolonged proliferation
of cardiomyocytes. However, this proliferative pheno-continuous surface oriented away from the DNA binding
site, mediate protein-protein interactions (Wilson et al., type is transient, and mutant myocytes ultimately exit
the cell cycle. It is intriguing that these mutant embryos1995). Within this region, position 22 is critical in de-
termining the specificity of such interactions. Homolo- exhibit a hypercellular cardiac phenotype, seemingly
opposite to that of embryos that die at E11.5. How cangies among the SRF-interacting homeodomains of HOP,
Nkx2.5, prx1, and Barx2 are shown in Figure 1B. There the antithetical phenotypes of the two classes of HOP
mutants be explained? One possibility is that they reflectare apparent identities among these homeodomains,
but they are divergent at position 22, suggesting that the dual functions of SRF as a regulator of muscle cell
proliferation and differentiation and the role of HOP inadditional determinants mediate their association with
SRF. In this regard, at least two separable subdomains modulating SRF activity (Figure 7). Early in development
when the myocardium must rapidly expand to sustainof the Nkx2.5 homeodomain have been shown to medi-
ate association with SRF (Chen and Schwartz, 1996). hemodynamic output, HOP may be required to dampen
the differentiation-inducing activity of SRF, thereby fa-SRF recruits myocardin, which is expressed specifi-
cally in cardiac and smooth muscle cell lineages, to voring proliferation of cardiomyocytes. Conversely, at
later stages, HOP may negatively regulate the growth-activate transcription through the CArG box (Wang et
al., 2001). Our results show that HOP can diminish the promoting function of SRF thereby promoting terminal
differentiation. Based on the ability of HOP to diminishcooperativity between SRF and myocardin. We presume
this reflects the inhibition of SRF DNA binding by HOP, SRF activity, the absence of HOP would be predicted
but it is also possible that HOP and myocardin compete to result in either precocious withdrawal of myocytes
for interaction with SRF. from the cell cycle or a failure of myocytes to differenti-
ate properly. We also cannot exclude the possibility that
Regulation of HOP Expression HOP has targets in addition to SRF that contribute to
in the Developing Heart the mutant phenotype.
The loss of HOP expression in Nkx2.5 mutant embryos The dual roles of SRF in cell proliferation and muscle
suggests that Nkx2.5 acts upstream of HOP in a cascade cell differentiation are well established (Poser et al.,
of cardiogenic regulators. Consistent with this notion, 2000; Vandromme et al., 1992; Croissant et al., 1996).
we have identified a 1.2 kb cardiac enhancer upstream SRF binds CArG box sequences in the control regions
of HOP that contains multiple Nkx2.5 binding sites (data of growth-regulated and muscle-specific genes (re-
not shown). viewed in Reecy et al., 1998). Consistent with the notion
The process of cardiac development is exquisitely that SRF activity is augmented in the absence of HOP,
sensitive to the level of Nkx2.5 expression and activity. numerous CArG box-dependent genes were upregu-
Haploinsufficiency of Nkx2.5 expression in mice and lated in HOP mutant hearts. Studies in skeletal muscle
humans results in cardiac structural abnormalities and cells that express SRF antisense RNA under control of
conduction defects (Schott et al., 1998). Conversely, a steroid-inducible promoter have demonstrated that
overexpression of Nkx2.5 in transgenic mice results in relatively minor changes in SRF activity can differentially
embryonic lethality due to abnormal cardiac morpho- affect cell proliferation or differentiation (Soulez et al.,
genesis (Kasahara et al., 2001). Overexpression of 1996). At intermediate levels of SRF antisense RNA ex-
Nkx2.5 in frog and zebrafish embryos also results in pression, cells were able to proliferate, but not differenti-
expansion of the cardiac field with resulting enlargement ate, whereas further elevation of SRF antisense expres-
of the heart (Chen and Fishman, 1996; Cleaver et al., sion blocked proliferation. The ability of SRF to regulate
1996). Thus, mechanisms must exist to precisely govern the opposing processes of proliferation and muscle cell
Nkx2.5 activity during development. HOP acts indirectly differentiation is dependent on its association with posi-
to modulate Nkx2.5 activity by suppressing the activity tive and negative cofactors and on intracellular signaling
of SRF, a key cardiogenic cofactor for Nkx2.5. and is consistent with the antithetical cardiac pheno-
types of HOP mutant mice.
In skeletal and smooth muscle cells, proliferation andRegulating the Balance of Cardiac Growth
and Differentiation differentiation are mutually exclusive processes. In con-
trast, cardiac myocytes can divide and differentiate si-Prior to E11.5, HOP is expressed throughout the devel-
oping myocardium. However, after this point, HOP ex- multaneously during early development, but terminal
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targeting vector and doubly selected in G418 and FIAU. ES clonesdifferentiation of cardiomyocytes is associated with irre-
were picked and homologous recombination was confirmed byversible cell cycle exit. The segregation of HOP mutants
Southern analysis. Recombinant ES cell clones were injected intointo two distinct classes with opposite phenotypes sug-
blastocysts obtained from C57BL6/J females. Chimeras were mated
gests that HOP participates in a very finely tuned mecha- with C57BL6/J females to obtain F1 mice carrying the targeted allele.
nism that governs the balance between cardiomyocyte Mice were generated in the isogenic 129/Sv background by breeding
the chimeras with 129/Sv females.proliferation and differentiation. While HOP acts as a
negative modulator of SRF, it does not completely re-
Immunohistochemistrypress SRF activity. This partial effect of HOP on SRF
Histological sectioning and staining with hematoxylin/eosin wereactivity may explain why HOP mutants segregate into
performed according to standard techniques. For immunostaining,two classes rather than showing a single phenotype.
sections were deparaffinized in xylene, rehydrated through graded
The variable penetrance of HOP mutant phenotypes also ethanols to PBS, and permeabilized in 0.3% Triton X-100 in PBS.
suggests the existence of modifier genes that influence Nonspecific binding was blocked by 1.5% normal goat serum in
PBS and anti-phospho-histone H3 rabbit antibody (Upstate Biotech-the activity of SRF, which is not surprising given the
nology) was applied at a 1:200 dilution in 0.1% BSA in PBS overnightplethora of cofactors and signaling pathways that modu-
at 4C. Sections were washed in PBS and fluorescein-conjugatedlate SRF activity.
anti-rabbit antibody (Vector Laboratories) was applied at a 1:200While we favor the interpretation that HOP exerts its
dilution in 1% normal goat serum for 1 hr.
effects on cardiomyocytes in a cell-autonomous man-
ner, it is formally possible that HOP also has effects Quantification of Cardiomyocyte Cell Numbers
on other cell types that influence cardiac growth and Cardiomyocytes from neonatal and adult hearts were isolated using
an alkaline dissociation method (Tamura et al., 1998) with minordevelopment. It is notable in this regard that other thin-
modifications. In brief, hearts were dissected, placed in 10% neutral-walled myocardial phenotypes have been attributed to
buffered formalin, and fixed at 4C. Hearts were then treated withdefects in non-cardiac tissues (Wu et al., 1999). Thus
50% KOH overnight at 4C, followed by extensive washing in distilledfar, we have not detected defects in other tissues in
water. Specimens were dried before addition of PBS containing
which HOP is expressed, such as the liver and lung, in Hoechst 33342 to yield a final suspension of 10 mg fixed tissue/
mutant mice. ml. Cell suspension was diluted with an equal volume of PBS and 18
l were loaded onto a Fuchs-Rosenthal counting chamber (Hausser
Scientific). Cardiomyocytes in the counting chamber were distin-Implications for Congenital and Acquired
guished from fibroblasts by cytoplasmic size and phase contrast
Cardiac Disease microscopy. The total number of cardiomyocytes from each individ-
In addition to its role in myoblast proliferation and differ- ual heart was calculated using the following equation:
entiation, SRF is a target for a variety of stress-inducible Cell number  5000 	 number of cells/mm2 counting chamber 	
dilution factor 	 total volume. The total numbers of cardiomyocytessignaling pathways and has been implicated in repro-
from wild-type neonatal hearts using this method were in the rangegramming cardiac gene expression in response to hy-
of 106 , which is similar to reported values using other methodspertrophic signals. Overexpression of SRF under control
(Reiss et al., 1996; Liao et al., 2001).
of a cardiac promoter has recently been shown to result
in hypertrophic growth of the heart (Zhang et al., 2001b). Microarray Analysis
This is consistent with the phenotype of the subset of RNA was extracted from wild-type and mutant hearts using Trizol
HOP mutants, which show late-onset hypertrophy. In reagent (Gibco BRL). For each group, 3 hearts were pooled and
microarray analysis was performed twice. One hundred ng of totallight of the pivotal role of SRF in myocyte growth and
RNA was amplified using the Atlas SMART Probe Amplification Kitdifferentiation, it will be interesting to examine the po-
(Clontech). The optimum number of PCR amplification cycles wastential involvement of HOP in acquired and congenital
determined following the manufacturer’s instructions. After the gen-
forms of heart disease. eration of cDNA, 3 amplification reactions were subjected to 19
cycles of PCR using a MWG Primus HT thermocycler. The 3 reac-
Experimental Procedures tions were pooled and unreacted PCR primers and dNTP’s were
removed using a QIAquick PCR purification kit (Qiagen). Amplified
Cloning and Sequencing of HOP cDNA was labeled using a modification of the Bioprime DNA labeling
In order to identify novel heart-enriched homeodomain proteins, kit (Invitrogen). It was then added to a microarray containing 27,648
EST databases were screened using a consensus sequence for the murine cDNA elements and incubated at 50C for 18–24 hr. The
homeodomain. EST AA222563, which encodes HOP, was isolated arrays were washed, scanned on an Axon GenePix 4000, and the
from a 6-week-old mouse heart cDNA library. Full-length cDNA signal intensities for each element were determined using Gene Pix
clones were obtained by 5
 rapid amplification of cDNA ends (RACE) Pro (Axon) as described (Wei et al., 2002).
and by screening a mouse heart cDNA library (Stratagene) with the Microarray analysis was performed in duplicate, reversing the
EST as a probe. Cy-Dyes. The data was preprocessed with an intensity dependent
normalization factor (Yang et al., 2002) derived from the Lowess
RNA and In Situ Hybridization Analysis function contained in the R statistical package. After the prepro-
A mouse multiple tissue Northern blot (Clontech) was hybridized cessing, the data was imported into a custom Access database and
under high stringency conditions with a 32P-labeled probe prepared queried for an expression log ratio of greater than 1 or less than 1,
from EST A222563 to detect HOP transcripts in adult tissues. In situ reproducibility in dye swap arrays, and a minimum median signal
hybridization of whole embryos or paraffin sections was performed intensity of twice local background.
as described (Passier et al., 2000). Identical bright and dark field
images were captured and silver grains were pseudo-colored red Glutathione S-Transferase Pull-Down Assays
using Adobe Photoshop, after which images were superimposed. A cDNA encoding the complete 508 amino acid human SRF protein
was cloned in-frame to Glutathione-S-Transferase (GST) in the
pGEX-KG vector. GST-SRF fusion protein was expressed and puri-Generation of HOP Mutant Mice
The HOP targeting vector was constructed in a plasmid containing fied as described (Guan and Dixon, 1991). HOP protein was trans-
lated in a rabbit reticulocyte lysate (Promega) supplemented withnuclear LacZ (nLacZ), PolNeo, and HSV-TK cassettes. SM-1 ES cells
derived from a 129/SvEv mouse strain were electroporated with the [35S]-methionine. For GST-pull-down assays, equal amounts of GST-
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